Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal Dysfunction

NCT01708889 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B Virus Infection
Chronic Hepatitis C Virus Infection

Interventions

BIOLOGICAL: BMS-914143 (Peginterferon Lambda-1a)

Sponsor

Bristol-Myers Squibb